ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $3.48 billion. The enterprise value is $4.80 billion.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.52 million shares outstanding. The number of shares has increased by 1.23% in one year.
| Current Share Class | 24.52M |
| Shares Outstanding | 24.52M |
| Shares Change (YoY) | +1.23% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 5.90% |
| Owned by Institutions (%) | 100.05% |
| Float | 22.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 20.83 |
| PS Ratio | 1.45 |
| Forward PS | 1.43 |
| PB Ratio | 1.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.92 |
| P/OCF Ratio | 17.06 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.16, with an EV/FCF ratio of 38.53.
| EV / Earnings | n/a |
| EV / Sales | 2.02 |
| EV / EBITDA | 15.16 |
| EV / EBIT | 49.31 |
| EV / FCF | 38.53 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.84.
| Current Ratio | 2.59 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | 4.85 |
| Debt / FCF | 13.18 |
| Interest Coverage | 0.91 |
Financial Efficiency
Return on equity (ROE) is -5.76% and return on invested capital (ROIC) is 1.64%.
| Return on Equity (ROE) | -5.76% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 1.64% |
| Return on Capital Employed (ROCE) | 2.67% |
| Revenue Per Employee | $170,146 |
| Profits Per Employee | -$8,406 |
| Employee Count | 14,000 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, ICU Medical has paid $51.68 million in taxes.
| Income Tax | 51.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.16% in the last 52 weeks. The beta is 0.74, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +37.16% |
| 50-Day Moving Average | 158.68 |
| 200-Day Moving Average | 152.05 |
| Relative Strength Index (RSI) | 31.62 |
| Average Volume (20 Days) | 237,936 |
Short Selling Information
The latest short interest is 786,379, so 3.21% of the outstanding shares have been sold short.
| Short Interest | 786,379 |
| Short Previous Month | 729,599 |
| Short % of Shares Out | 3.21% |
| Short % of Float | 3.48% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.38 billion and -$117.69 million in losses. Loss per share was -$4.83.
| Revenue | 2.38B |
| Gross Profit | 824.78M |
| Operating Income | 97.41M |
| Pretax Income | -98.35M |
| Net Income | -117.69M |
| EBITDA | 316.92M |
| EBIT | 97.41M |
| Loss Per Share | -$4.83 |
Full Income StatementBalance Sheet
The company has $320.81 million in cash and $1.64 billion in debt, giving a net cash position of -$1.32 billion or -$53.91 per share.
| Cash & Cash Equivalents | 320.81M |
| Total Debt | 1.64B |
| Net Cash | -1.32B |
| Net Cash Per Share | -$53.91 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 80.16 |
| Working Capital | 885.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $204.03 million and capital expenditures -$79.37 million, giving a free cash flow of $124.66 million.
| Operating Cash Flow | 204.03M |
| Capital Expenditures | -79.37M |
| Free Cash Flow | 124.66M |
| FCF Per Share | $5.08 |
Full Cash Flow StatementMargins
Gross margin is 34.62%, with operating and profit margins of 4.09% and -4.94%.
| Gross Margin | 34.62% |
| Operating Margin | 4.09% |
| Pretax Margin | -2.77% |
| Profit Margin | -4.94% |
| EBITDA Margin | 13.30% |
| EBIT Margin | 4.09% |
| FCF Margin | 5.23% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.38% |
| FCF Yield | 3.58% |
Dividend DetailsAnalyst Forecast
The average price target for ICU Medical is $199.67, which is 40.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $199.67 |
| Price Target Difference | 40.64% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 0.25% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 1.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 7 |